This article is more than 5 years old. Information may no longer be current.
Onkos Surgical receives FDA 510(k) clearance for Eleos limb salvage system
Click Here to Manage Email Alerts
Onkos Surgical announced it has received FDA 510(k) clearance to market the Eleos limb salvage system to treat patients with significant bone loss due to cancer, trauma or previous surgical procedures.
“Surgical oncology has been an underserved market for some time,” Patrick Treacy, founder and chief executive officer of Onkos Surgical, said in a company press release. “These surgeons and patients deserve more. With the introduction of the Eleos limb salvage system, we will continue to build on our promise of delivering meaningful innovation in the orthopedic oncology market. Our company is focused and dedicated to bringing solutions to this group of surgeons and patients that will address the significant unmet need that exists. Today is a[n] important milestone for our company and we look forward to executing on our robust pipeline of innovation.”
Reference: